Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease

被引：30

作者：

Silvestrini, Mauro ^{[1
]}

Viticchi, Giovanna ^{[1
]}

Altamura, Claudia ^{[2
]}

Luzzi, Simona ^{[1
]}

Balucani, Clotilde ^{[3
]}

Vernieri, Fabrizio ^{[2
]}

机构：

[1] Univ Politecn Marche, Neurol Clin, I-60020 Ancona, Italy

[2] Campus Biomed Univ, Neurol Clin, Rome, Italy

[3] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA

来源：

JOURNAL OF ALZHEIMERS DISEASE | 2012年 / 32卷 / 03期

关键词：

Alzheimer's disease; vascular markers; vascular risk factors; WHITE-MATTER LESIONS; MILD COGNITIVE IMPAIRMENT; INTIMA-MEDIA THICKNESS; CEREBRAL VASOMOTOR REACTIVITY; GLYCATION END-PRODUCTS; MIDLIFE BLOOD-PRESSURE; APOLIPOPROTEIN-E; CAROTID ATHEROSCLEROSIS; AMYLOID-BETA; ATRIAL-FIBRILLATION;

D O I：

10.3233/JAD-2012-121240

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Increasing evidence is emerging that vascular disease and its risk factors play a role in the development of Alzheimer's disease (AD) and affect the probability of an adverse outcome. The aims of this review are to explore the relationship between vascular risk factors and AD and to discuss the potential use of vascular markers in the clinical approach to cognitive impairment. Moreover, we present evidence about the potential use of ultrasonographic and neuroradiologic markers of cognitive impairment in order to establish possible treatment strategies in subjects with a clinical profile at risk of developing AD.

引用

页码：689 / 698

页数：10

共 50 条

[31] Loss-of-function mutation in ABCA1 and risk of Alzheimer's disease and cerebrovascular disease
Nordestgaard, Liv Tybjaerg
Tybjaerg-Hansen, Anne
Nordestgaard, Borge G.
Frikke-Schmidt, Ruth
ALZHEIMERS & DEMENTIA, 2015, 11 (12) : 1430 - 1438
[32] Clinical assessment of the genetic risk functions in Alzheimer's disease
Kamino, K
Kida, T
Takeda, M
Molecular Neurobiology of Alzheimer Disease and Related Disorders, 2004, : 71 - 78
[33] Long-term treatment with galantamine in patients with Alzheimer's disease and Alzheimer's disease with cerebrovascular disease
Feldman, H
Van Baelen, B
Brashear, HR
Schwalen, S
Kavanagh, S
NEUROBIOLOGY OF AGING, 2004, 25 : S198 - S199
[34] ISCHEMIC CEREBROVASCULAR DISEASE - ASSESSMENT OF RISK FACTORS
GERTLER, MM
RUSK, HA
WHITER, HH
LEETMA, HE
EHRENKRA.M
GERIATRICS, 1968, 23 (03) : 135 - &
[35] Cerebrovascular phenotypes in mouse models of Alzheimer's disease
Szu, Jenny, I
Obenaus, Andre
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (08): : 1821 - 1841
[36] Loneliness, cerebrovascular and Alzheimer's disease pathology, and cognition
Lao, Patrick
Young, Christina B.
Ezeh, Chima
Lacayo, Bayardo
Seblova, Dominika
Andrews, Ryan M.
Gibbons, Laura
Kraal, A. Zarina
Turney, Indira
Deters, Kacie D.
Dotson, Vonetta
Manly, Jennifer J.
Barnes, Lisa L.
Zahodne, Laura B.
ALZHEIMERS & DEMENTIA, 2024, 20 (10) : 7113 - 7123
[37] Cerebrovascular gene linked to Alzheimer's disease pathology
de la Torre, JC
TRENDS IN MOLECULAR MEDICINE, 2005, 11 (12) : 534 - 536
[38] Cerebrovascular insulin receptors are defective in Alzheimer's disease
Leclerc, Manon
Bourassa, Philippe
Tremblay, Cyntia
Caron, Vicky
Sugere, Camille
Emond, Vincent
Bennett, David A.
Calon, Frederic
BRAIN, 2023, 146 (01) : 75 - 90
[39] Managing treatment expectations in dementia due to cerebrovascular disease or to combined Alzheimer's disease and cerebrovascular disease
Kurz, A
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 380 - 380
[40] Cerebrovascular pathology in Alzheimer's disease: Conference summary
不详
STROKE, 1997, 28 (07) : B4 - B5

← 1 2 3 4 5 →